Effect of Neutralizing Monoclonal Antibody Treatment on Virologic and Immunologic Biomarkers in Patients With COVID-19, SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy, and Optimization of Antiviral Therapy in Immunocompromised COVID-19 Patients

92 views
November 27, 2023
0 Comments
Login to view comments. Click here to Login